Key facts
- Notable investors include ImpactU (United Kingdom).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for SeraCares
- ·The full record, as it builds
Funding rounds
No funding rounds for SeraCares are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SeraCares
Developer of a diagnostic quality control platform intended to support accuracy and reliability in clinical laboratory testing. The company offers third-party quality controls, reference materials, and proficiency support tools across molecular diagnostics, serology, and infectious disease testing, enabling clinical laboratories and diagnostic manufacturers to ensure consistent performance, meet regulatory requirements, and improve confidence in test results.
- Sector
- Healthcare
- HQ
- Oxford, United Kingdom
- Founded
- 2013
- Employees
- 8
- Website
- seracares.com/
- Ownership
- Privately Held (backing)
SeraCares doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SeraCares shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SeraCares in its N-PORT filings yet. We sweep new filings monthly.